Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

REC8 Polyclonal Antibody, APC Conjugated

Product Specifications

Background

Required during meiosis for separation of sister chromatids and homologous chromosomes. Proteolytic cleavage of REC8 on chromosome arms by separin during anaphase I allows for homologous chromosome separation in meiosis I and cleavage of REC8 on centromeres during anaphase II allows for sister chromatid separation in meiosis II (By similarity) .

Synonyms

Rec8p; REC8L1; HR21spB; Meiotic recombination protein REC8 homolog; Cohesin Rec8p; REC8

Gene ID

9985

Swiss Prot

O95072

Cellular Locus

Nucleus

Host

Rabbit

Cross Reactivity

Human, Mouse, Rat

Immunogen

22-120/547

Target

REC8

Clonality

Polyclonal

Conjugation

APC

Source

KLH conjugated synthetic peptide derived from human REC8

Applications

WB, FCM, IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

650nm/660nm

Concentration

1ug/ul

Dilution

WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Prediction Reactivity

Dog, Pig, Horse, Rabbit, GuineaPig

Gene ID URL

9985

Isotype

IgG

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

3,4-Diaminopyridine
270820-01 5 g

3,4-Diaminopyridine

Ask
View Details
3,4-Diaminopyridine
270820-02 10 g

3,4-Diaminopyridine

Ask
View Details
3,4-Diaminopyridine
270820-03 25 g

3,4-Diaminopyridine

Ask
View Details
3,4-Diaminopyridine
270820-04 50 g

3,4-Diaminopyridine

Ask
View Details
3,4-Diaminopyridine
270820-05 100 g

3,4-Diaminopyridine

Ask
View Details
CUG-BP2 (h) -PR
sc-44554-PR 10 µM - 20 µL

CUG-BP2 (h) -PR

Ask
View Details